Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma

This publication has 49 references indexed in Scilit:

• A pan-cancer study of spalt-like transcription factors 1/2/3/4 as therapeutic targets
  Archives of Biochemistry and Biophysics, 2021
• UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation
  Cancer Letters, 2020
• Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells
  Asian Journal of Pharmaceutical Sciences, 2020
• Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma
  The International Journal of Biochemistry & Cell Biology, 2020
• Stilbenoid‐Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor
  Molecular Nutrition & Food Research, 2019
• Milk exosomes - Natural nanoparticles for siRNA delivery
  Cancer Letters, 2019
• Sarcolipin Signaling Promotes Mitochondrial Biogenesis and Oxidative Metabolism in Skeletal Muscle
  Cell Reports, 2018
• The CCCTC‐binding factor (CTCF)–forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma
  The Journal of Pathology, 2017
• A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
  Biomaterials, 2014
• The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
  Cell, 2008